SCHEMBL865155

SCHEMBL865155

C=CCCCOC(=O)C=C

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.71
ALDH1A1 P00352 6/20 0.71
CYP3A4 P08684 2/20 0.71
HPGD P15428 1/20 0.63
TP53 P04637 3/20 0.58
HIF1A Q16665 3/20 0.58
HSD17B10 Q99714 1/20 0.58
ATM Q13315 1/20 0.45
THRB P10828 2/20 0.43
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ABCC4 O15439 1/20 0.40
MAPT P10636 1/20 0.40
HCAR2 Q8TDS4 3/20 0.39
LMNA P02545 1/20 0.39
LPAR2 Q9HBW0 1/20 0.39
LPAR3 Q9UBY5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL85963 0.93 TSHR (0.75) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23322205 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23321776 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL85968 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23322129 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23321842 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23321612 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23322045 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23321590 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL23321665 0.91 ALDH1A1 (0.79) TSHRALDH1A1CYP3A4HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040132911-A1 Predispersions, process for their preparation, compositions therefor, process for the preparation of such compositions SHARMA VIPIN (IN) 2004-07-08 US claimed
EP-1373373-A2 PREDISPERSIONS, COMPOSITIONS THEREFOR AND PROCESSES FOR PREPARING SAME Sharma, Vipin (IN) 2004-01-02 EP claimed
WO-2002072675-A9 PREDISPERSIONS, COMPOSITIONS THEREFORE, AND PROCESSES FOR PREPARING SAME SHARMA VIPIN (IN) 2002-11-21 WO claimed
WO-2002072675-A2 PREDISPERSIONS, COMPOSITIONS THEREFORE, AND PROCESSES FOR PREPARING SAME SHARMA VIPIN (IN) 2002-09-19 WO claimed
EP-3819301-B1 PREPARATION OF ORGANOSILICON COMPOUND HAVING (METH)ACRYLOYLOXY GROUP SHINETSU CHEMICAL CO (JP) 2025-08-06 EP disclosed
CN-118027412-A Photo-alignment material 罗利克技术有限公司 2024-05-14 CN disclosed
CN-109923711-B Binder composition for lithium battery 富士胶片和光纯药株式会社 2023-06-27 CN disclosed
US-11634544-B2 Photoaligning materials Rolic Technologies AG (CH) 2023-04-25 US disclosed
CN-109937500-B Binder composition for lithium battery electrode and electrode using same 富士胶片和光纯药株式会社 2023-04-11 CN disclosed
EP-3579312-B1 USE OF A BINDER AGENT COMPOSITION FOR LITHIUM BATTERY, SLURRY COMPOSITION FOR LITHIUM BATTERIES COMPRISING THE BINDER COMPOSITION, AND ELECTRODE USING THE BINDER COMPOSITION FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2022-07-27 EP disclosed
EP-3579313-B1 USE OF A BINDER AGENT COMPOSITION FOR LITHIUM BATTERY, SLURRY COMPOSITION FOR LITHIUM BATTERIES COMPRISING THE BINDER COMPOSITION, AND ELECTRODE USING THE BINDER COMPOSITION FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2022-07-27 EP disclosed
US-11377455-B2 Preparation of organosilicon compound having (meth)acryloyloxy group SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-07-05 US disclosed
WO-2008135131-A1 THERMALLY STABLE ALIGNMENT MATERIALS ROLIC AG (CH) 2008-11-13 WO disclosed
EP-1966119-A1 PHOTOCROSSLINKABLE MATERIALS Rolic AG (CH) 2008-09-10 EP disclosed
EP-1860094-A1 Photocrosslinkable materials Rolic AG (CH) 2007-11-28 EP disclosed
WO-2007071091-A1 PHOTOCROSSLINKABLE MATERIALS ROLIC AG (CH) 2007-06-28 WO disclosed
US-20040132911-A1 Predispersions, process for their preparation, compositions therefor, process for the preparation of such compositions SHARMA VIPIN (IN) 2004-07-08 US disclosed
EP-1373373-A2 PREDISPERSIONS, COMPOSITIONS THEREFOR AND PROCESSES FOR PREPARING SAME Sharma, Vipin (IN) 2004-01-02 EP disclosed
WO-2002072675-A9 PREDISPERSIONS, COMPOSITIONS THEREFORE, AND PROCESSES FOR PREPARING SAME SHARMA VIPIN (IN) 2002-11-21 WO disclosed
WO-2002072675-A2 PREDISPERSIONS, COMPOSITIONS THEREFORE, AND PROCESSES FOR PREPARING SAME SHARMA VIPIN (IN) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11377455-B2 Preparation of organosilicon compound having (meth)acryloyloxy group H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MMAB, ACR TSHR 1239/4885ALDH1A1 2631/4885CYP3A4 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.